Early detection of colonic polyps and their prompt removal is a fundamental goal of colorectal cancer screening and prevention. Results of a new multicentre study demonstrate sensitivity for the ScheBo M2-PK Quick test of 92.8% for bowel cancer and 69.4% for polyps. The ScheBo M2-PK Quick test detected twice as many bowel cancer cases and nearly six times the number of polyps compared with an immunological faecal occult blood test (FIT) also included in the study.
HORIBA Medical is a renowned specialist in the design and manufacture of automated in-vitro diagnostic systems for analysis in haematology, clinical chemistry, and haemostasis. From compact point of care (POC) solutions to high throughput laboratory systems, HORIBA Medical has successfully developed an array of analysers and data management...
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
Rome, Italy
10-11 April, 2025
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Royal College Of Physicians Of Edinburgh
15 May, 2025
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
